Use of sGC stimulators for the treatment of non-alcoholic steatohepatitis (NASH)

摘要

The present disclosure provides a method, use, for treating non-alcoholic steatohepatitis (NASH) comprising an sGC stimulant or a pharmaceutically acceptable salt thereof, alone or in combination with one or more additional therapeutic agents. It relates to pharmaceutical compositions and kits. 【Selection chart】 None